Related Experiment Video
Updated: Jun 3, 2026

Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
Seizure preconditioning and epileptic tolerance: models and mechanisms
Eva M Jimenez-Mateos1, David C Henshall
1Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland Dublin, Ireland.
Brief seizures activate natural brain defenses, creating temporary tolerance to prolonged seizures (status epilepticus). This protective mechanism, studied in animal models, offers potential for new neuroprotection and anti-epileptogenesis strategies.
Area of Science:
- Neuroscience
- Epileptology
- Molecular Biology
Background:
- Brief seizures can trigger endogenous protective mechanisms, conferring temporary tolerance to subsequent harmful seizures like status epilepticus.
- Existing research utilizes various preconditioning methods (e.g., electroconvulsive shocks, kainic acid) to induce and study epileptic tolerance.
- The precise molecular and cellular pathways mediating this protection remain incompletely understood.
Purpose of the Study:
- To review animal models of epileptic tolerance.
- To identify key molecular and cellular effectors involved in seizure preconditioning.
- To explore the potential of epileptic tolerance as a paradigm for discovering neuroprotective and anti-epileptogenic targets.
Main Methods:
- Review of existing literature on animal models of epileptic tolerance.
- Analysis of proposed molecular mediators, including transcription factors (NfκB), ion channels, growth factors, and apoptosis-related proteins (Bcl-2 family).
- Integration of findings from transcriptomic profiling (microarrays) of seizure preconditioning.
Main Results:
- Seizure preconditioning activates endogenous protective programs, reducing brain susceptibility to status epilepticus-induced damage.
- Proposed mediators include NfκB, altered ion channel expression, growth factor upregulation, and suppression of pro-apoptotic proteins.
- Transcriptomic analysis reveals roles for chromatin remodeling and suggests preconditioning establishes an anti-excitotoxicity phenotype.
Conclusions:
- Epileptic tolerance is a demonstrable phenomenon offering insights into neuroprotection.
- Understanding the mechanisms of tolerance can guide the development of novel therapeutic targets for epilepsy and brain injury.
- This experimental paradigm is valuable for identifying strategies to prevent excitotoxicity and epileptogenesis.
More Related Videos
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists

